fusion
machineri
herpesviru
entri
host
cell
involv
interact
viral
glycoprotein
cellular
receptor
although
addit
viral
cellular
domain
requir
extens
area
plasma
membran
surfac
consist
lipid
raft
organ
cholesterolrich
microdomain
involv
signal
transduct
protein
sort
membran
transport
mani
process
virus
infect
extract
cholesterol
lead
disorgan
lipid
microdomain
dissoci
protein
bound
lipid
raft
investig
effect
cholesterol
deplet
caprin
herpesviru
three
import
phase
viru
infect
bind
entri
postentri
treatment
prejudic
viru
bind
cell
dosedepend
reduct
viru
yield
observ
viru
entri
stage
mm
reduc
infect
evid
treatment
mdbk
viru
entri
reveal
moder
inhibitori
effect
suggest
cholesterol
mainli
requir
viru
entri
rather
postentri
stage
alter
envelop
lipid
composit
affect
viru
entri
notic
reduct
viru
infect
detect
presenc
mm
consid
recognit
host
cell
receptor
crucial
step
startup
phase
infect
data
essenti
studi
pathogenesi
date
viru
receptor
cphv
yet
identifi
investig
requir
state
treatment
affect
express
viral
receptor
caprin
herpesviru
associ
two
differ
syndrom
goat
depend
age
anim
time
infect
kid
may
caus
gener
lethal
diseas
affect
mainli
digest
tract
adult
goat
clinic
manifest
involv
respiratori
reproduct
tract
accord
site
viru
entri
although
infect
preferenti
genit
mucosa
follow
primari
genit
infect
replic
mucos
epithelium
spread
sacral
ganglia
establish
latent
infect
tempesta
et
al
member
herpesvirida
form
larg
variou
famili
viru
compris
three
subfamili
design
alpha
beta
gamma
herpesvirus
base
antigen
genet
properti
belong
cluster
rumin
alphaherpesvirus
close
relat
bovin
herpesviru
thiri
et
al
virion
compos
larg
dna
genom
encas
icosahedr
capsid
turn
coat
layer
protein
call
tegument
envelop
compos
dozen
viral
protein
glycoprotein
lipid
bilay
herpesvirus
rel
broad
host
rang
cultur
cell
least
entri
obviou
interfer
virus
use
multipl
cell
surfac
receptor
entri
recogn
structur
featur
receptor
conserv
among
human
anim
speci
spear
et
al
basic
fusion
machineri
herpesviru
entri
includ
five
viral
glycoprotein
design
gb
gc
gd
gh
gl
although
addit
viral
bindingreceptor
may
also
requir
least
four
envelop
glycoprotein
gb
gd
gh
gl
absolut
essenti
shukla
spear
spear
longneck
viral
fusogen
function
unless
anchor
membran
virion
envelop
cell
surfac
chang
conform
expos
anoth
hydrophob
domain
fusion
peptid
enabl
insert
target
membran
four
essenti
glycoprotein
thought
act
concert
induc
fusion
viral
envelop
cell
membran
cell
entri
receptor
requir
trigger
fusion
viral
ligand
known
herp
simplex
viru
hsv
entri
receptor
gd
summari
requir
entri
appli
anim
alphaherpesvirus
well
includ
pseudorabi
viru
prv
molecul
hsv
glycoprotein
associ
necessarili
protein
could
lipid
moieti
sinc
viru
associ
lipid
vesicl
contain
protein
bender
et
al
spear
et
al
herpesvirus
notabl
except
epstein
barr
viru
ebv
make
initi
contact
cell
bind
viral
glycoprotein
glycosaminoglycan
usual
heparan
sulfat
cell
surfac
proteoglycan
bind
heparan
sulphat
greatli
increas
effici
viral
entri
may
essenti
viru
infect
mediat
viral
glycoprotein
shukla
spear
suppos
interact
one
viral
glycoprotein
cellular
receptor
could
trigger
envelopemembran
fusion
celltocel
fusion
base
data
sever
studi
focus
identif
viral
cellular
domain
involv
interact
viru
cell
alphaherpesvirus
gammaherpesvirus
bind
cell
mediat
virion
glycoprotein
essenti
entri
entri
requir
interact
viral
ligand
anoth
cell
surfac
receptor
entri
receptor
discov
date
fall
three
class
spear
et
al
includ
herpesviru
entri
mediat
hvem
member
tumor
necrosi
factor
tnf
receptor
famili
two
member
immunoglobulin
superfamili
specif
site
heparan
sulfat
gener
certain
isoform
spear
et
al
hsv
virion
gd
ligand
sever
cell
surfac
receptor
hvem
nectin
heparan
sulfat
one
mediat
entri
entri
process
studi
detail
mani
herpesvirus
particular
interact
hsv
prv
cellular
receptor
spear
longneck
analyz
interact
hsv
gd
entri
receptor
justifi
viral
entri
cell
fusion
bind
gd
one
receptor
result
conform
chang
gd
enabl
interact
gb
ghgl
activ
fusogen
activ
probabl
gd
integr
compon
basic
fusion
machineri
moreov
receptor
gb
andor
ghgl
may
exist
bind
either
receptor
could
also
trigger
fusion
activ
bypass
requir
gd
observ
emerg
part
result
obtain
prv
use
sever
human
anim
member
nectin
famili
entri
receptor
also
one
gammaherpesvirus
human
herpesviru
shown
requir
gb
gh
gl
cell
fusion
although
possibl
potenti
activ
viral
protein
rule
pertel
entri
receptor
epitheli
cell
yet
identifi
could
includ
integrin
viral
ligand
could
gh
andor
entri
gb
bind
one
integrin
one
interact
viral
ligand
entri
receptor
thought
activ
fusion
activ
gb
ghgl
spear
longneck
extens
area
plasma
membran
surfac
consist
lipid
raft
lipid
raft
hypothesi
propos
cell
membran
organ
distinct
cholesterolrich
microdomain
import
signal
transduct
protein
sort
membran
transport
brown
london
ikonen
chung
et
al
lipid
raft
enrich
glycosphingolipid
sphingomyelin
cholesterol
associ
protein
play
critic
role
differ
biolog
aspect
life
cycl
differ
virus
particular
involv
mani
process
virus
infect
pratelli
colao
tight
packag
sphingolipid
maintain
presenc
cholesterol
major
constitu
lipid
raft
sever
protein
partit
membran
domain
imhoff
et
al
sinc
lipid
raft
rich
sphingolipid
cholesterol
resist
deterg
extract
usual
method
choic
separ
physic
lipid
raft
membran
compon
contrari
deriv
cyclic
oligom
glucos
lipophil
properti
pitha
et
al
extract
cholesterol
membran
disrupt
lipid
raft
format
cell
consequ
block
biolog
process
depend
lipid
raft
chung
et
al
pratelli
colao
sinc
cholesterolenrich
cell
viral
membran
involv
entri
process
sever
envelop
virus
test
import
cholesterol
plasma
membran
entri
mammalian
cell
use
cholesterol
sequest
drug
madin
darbi
bovin
kidney
mdbk
cell
line
deriv
kidney
appar
normal
adult
steer
madin
darbi
cell
maintain
dulbecco
minim
essenti
medium
dmem
supplement
foetal
calf
serum
fc
passag
twice
week
strain
buonavoglia
et
al
use
throughout
experi
viru
propag
mdbk
cell
line
grown
serumfre
medium
cytophat
effect
detect
h
characterist
chang
develop
enlarg
cell
take
retractil
appear
syncytia
variabl
degre
vacuol
round
stellat
cell
might
also
seen
viral
titr
determin
microtitr
plate
mdbk
cell
express
tissu
cultur
infecti
dose
tcid
l
calcul
use
reedmuench
formula
reed
muench
infect
titr
stock
viru
tcid
l
sigmaaldrich
strictli
surfaceact
drug
prefer
membran
lipid
remov
cholesterol
select
rapidli
plasma
membran
barman
nayak
cyclodextrin
cd
famili
cyclic
oligom
glucos
differ
number
glucos
unit
ring
ie
compos
six
seven
eight
glucos
unit
respect
et
al
highli
hydrophil
molecul
bind
therebi
solubil
hydrophob
molecul
iri
et
al
deriv
cd
solubl
less
toxic
use
pharmacolog
research
year
carrier
lipophil
drug
recent
employ
studi
effect
cholesterol
deplet
lipid
raft
disassembl
deriv
mostli
chosen
studi
extract
membran
cholesterol
effici
neglig
bind
lipid
et
al
order
avoid
toxic
effect
cellular
system
employ
adequ
time
treatment
rang
concentr
evalu
cell
viabil
assay
previous
report
carro
damont
briefli
mdbk
cell
grown
plate
incub
h
serumfre
dmem
contain
concentr
mm
number
viabl
cell
determin
trypan
blue
exclus
mdbk
cell
mock
treat
use
control
accord
data
obtain
treatment
condit
chosen
remov
plasma
membran
cholesterol
mdbk
cell
concentr
mm
dissolv
dmem
prepar
watersolubl
cholesterol
sigmaaldrich
employ
replenish
cholesterol
cellular
viral
plasma
membran
extract
use
cellular
viral
cholesterol
measur
use
amplex
red
cholesterol
assay
kit
invitrogenlif
technolog
accord
manufactur
instruct
report
pratelli
colao
cellular
cholesterol
determin
confluent
monolay
mdbk
grown
sixwel
plate
contain
approxim
equal
cell
number
treat
differ
concentr
rang
mm
time
monolay
mdbk
cell
sixwel
plate
pretreat
mm
replenish
variou
concentr
exogen
cholesterol
rang
gml
monolay
wash
three
time
dmem
trypsinis
edta
centrifug
g
c
min
remov
cellular
debri
pellet
suspend
l
reaction
buffer
homogen
needl
cellular
cholesterol
concentr
determin
three
time
amplex
red
cholesterol
assay
kit
use
spectrofluoromet
victor
perkinelm
nm
excit
nm
emiss
wavelength
nontreat
mdbk
cell
use
control
determin
viral
cholesterol
viral
sampl
contain
tcid
l
mm
untreat
viral
suspens
centrifug
g
c
min
remov
cellular
debri
ultra
centrifug
g
c
h
parallel
viral
suspens
stock
viru
pretreat
mm
replenish
exogen
watersolubl
cholesterol
appli
final
concentr
rang
gml
centrifug
report
pellet
suspend
l
reaction
buffer
homogen
subject
cholesterol
determin
three
time
amplex
red
cholesterol
assay
kit
mdbk
grown
serumfre
medium
avoid
cholesterol
measur
affect
serum
cholesterol
recogn
stage
cell
membran
cholesterol
requir
infect
effect
treatment
viru
bind
evalu
accord
protocol
zhu
et
al
mdbk
cell
grown
sixwel
plate
mock
treat
treat
mm
respect
min
c
cell
wash
twice
icecold
dmem
infect
tcid
l
icecold
medium
plate
incub
h
c
allow
viru
attach
cell
extens
wash
dmem
plate
frozen
thaw
three
time
cellassoci
titrat
mdbk
cell
describ
experi
repeat
three
time
investig
effect
cholesterol
deplet
viru
entri
mdbk
cell
grown
plate
wash
dmem
mock
pretreat
pretreat
concentr
mm
min
c
thereaft
cell
wash
dmem
remov
drug
inocul
tcid
l
incub
h
c
inocula
discard
treatment
citrat
buffer
mm
citric
acid
mm
kcl
mm
nacl
ph
exactli
min
inactiv
cell
membran
bound
unpenetr
virion
previous
describ
chung
et
al
zhu
et
al
cell
incub
c
dmem
without
compound
h
post
infect
plate
frozen
thaw
three
time
viru
yield
determin
viru
titrat
assay
mdbk
cell
describ
cholesterol
replenish
experi
monolay
mdbk
plate
mock
pretreat
pretreat
mm
min
c
report
mock
supplement
supplement
differ
concentr
exogen
cholesterol
rang
gml
dmem
incub
h
c
pratelli
colao
mock
cell
replenish
serumfre
dmem
cell
wash
twice
infect
h
c
treat
citrat
buffer
incub
h
co
incub
plate
frozen
thaw
three
time
viru
yield
determin
viru
titrat
assay
mdbk
cell
describ
experi
repeat
three
time
effect
cell
membran
cholesterol
deplet
postentri
stage
replic
evalu
report
zhu
et
al
mdbk
cell
seed
plate
preincub
tcid
l
h
co
incub
treatment
citrat
buffer
cell
treat
mm
min
c
test
two
control
prepar
control
cell
mock
treat
viru
infect
control
cell
pretreat
mm
infect
tcid
l
h
control
treat
citrat
buffer
infect
test
control
incub
h
determin
viru
yield
viru
titrat
assay
extens
freez
thaw
experi
repeat
three
time
investig
function
role
cholesterol
viral
envelop
infect
experiment
deplet
cholesterol
carri
viral
suspens
cholesterol
extract
tcid
l
incub
concentr
mm
min
c
viru
pellet
centrifug
g
h
c
remov
suspend
dmem
control
mock
treat
pellet
report
viru
infect
determin
well
mdbk
cell
describ
furthermor
verifi
whether
effect
cholesterol
deplet
revers
exogen
cholesterol
employ
replenish
viral
envelop
mock
treat
treat
mm
min
c
supernat
remov
ultra
centrifug
describ
viru
pellet
suspend
medium
medium
contain
exogen
cholesterol
rang
gml
incub
h
c
titrat
viru
titrat
assay
well
experi
repeat
three
time
cholesterol
content
cellular
viral
plasma
membran
determin
use
cholesterol
assay
kit
untreat
mdbk
cell
compar
treatment
result
dosedepend
reduct
cholesterol
content
incub
mm
cholesterol
content
endur
notic
reduct
comparison
untreat
cell
fig
mdbk
pretreat
mm
analyz
cholesterol
replenish
increas
amount
shown
fig
gml
exogen
cholesterol
restor
cholesterol
valu
cellular
membran
nearli
valu
determin
prior
treatment
cholesterol
content
untreat
suspens
determin
increas
drug
concentr
result
dosedepend
decreas
cholesterol
content
viral
membran
mm
reduc
evid
viral
cholesterol
compar
amount
found
untreat
virion
fig
cholesterol
deplet
virion
replenish
exogen
cholesterol
increas
amount
viru
pellet
use
cholesterol
measur
exogen
cholesterol
restor
viral
cholesterol
nearli
valu
determin
prior
treatment
fig
maximum
reduct
total
cellular
cholesterol
normal
level
wherea
maximum
reduct
viral
cholesterol
differ
presum
due
effect
limit
plasma
membran
cholesterol
remov
intracellular
membran
advers
effect
might
undermin
viru
infect
independ
cholesterol
reduct
valuat
measur
cell
viabil
drug
treatment
detriment
effect
detect
trypan
blue
stain
cell
count
h
treatment
concentr
mm
data
shown
employ
infect
mock
treat
treat
mdbk
cell
h
c
verifi
cellular
membran
cholesterol
deplet
essenti
bind
target
cell
cell
cultur
viru
yield
determin
viru
titrat
assay
report
fig
evid
decreas
viru
bind
mdbk
cell
compar
mock
treat
cell
observ
investig
cholesterol
target
cell
surfac
essenti
entri
mdbk
cell
mock
pretreat
pretreat
noncytotox
concentr
infect
follow
treatment
citrat
buffer
remov
cell
bound
unpenetr
virion
viru
yield
determin
viru
titrat
assay
shown
fig
effici
infect
mdbk
cell
compromis
treatment
dosedepend
manner
concentr
mm
reduct
infect
rate
evid
compar
mock
treat
control
cell
mm
select
consid
appropri
concentr
neglig
cell
toxic
effici
cholesterol
deplet
confirm
inhibitori
effect
entri
mdbk
cell
due
cholesterol
deplet
cell
membran
cholesterol
replenish
exogen
cholesterol
mdbk
cell
first
treat
mock
treat
exogen
cholesterol
rang
gml
use
replenish
viru
yield
determin
viru
titrat
assay
inhibitori
effect
partial
revers
cholesterol
replenish
gml
exogen
cholesterol
fig
cell
membran
cholesterol
deplet
postentri
stage
effect
replic
cell
membran
cholesterol
deplet
postentri
stage
partial
affect
viru
product
purpos
mdbk
cell
infect
h
cellbound
viru
inactiv
cell
treat
mm
min
test
incub
h
test
compar
treatment
viru
entri
control
reveal
moder
notic
inhibitori
effect
anyhow
suggest
cholesterol
mainli
involv
entri
mdbk
cell
rather
postentri
stage
fig
import
viral
cholesterol
infect
analys
cholesterol
deplet
viral
envelop
suspens
incub
mm
min
c
mock
treat
drug
remov
suspens
ultracentrifug
infect
determin
viru
titrat
assay
show
fig
exposur
result
dosedepend
inhibitori
effect
viru
infect
concentr
mm
viru
yield
suffer
notic
reduct
inhibitori
effect
viral
envelop
partial
restor
cholesterol
replenish
data
report
fig
demonstr
gml
exogen
cholesterol
reestablish
partial
viru
infect
confirm
envelop
cholesterol
also
requir
viru
infect
lipid
raft
involv
regul
differ
biolog
event
includ
membran
transport
signal
transduct
pathway
involv
specif
membran
microdomain
enrich
cholesterol
glyco
shingolipid
viru
entri
assembl
bud
demonstr
local
viral
structur
protein
effect
lipid
raftsdisrupt
agent
replic
process
sever
virus
suzuki
suzuki
recent
studi
demonstr
lipid
raft
play
critic
role
process
viral
infect
involv
membran
lipid
raft
entri
nonenvelop
virus
demonstr
simian
viru
rotaviru
echoviru
type
enteroviru
rhinoviru
human
adenoviru
subgroup
c
suzuki
suzuki
essenti
role
cholesterol
replic
cycl
also
clearli
establish
mani
envelop
virus
accumul
evid
suggest
envelop
viru
entri
may
requir
cholesterol
either
two
membran
involv
pratelli
colao
cholesterol
cellular
viral
membran
requir
infect
zhu
et
al
cell
membran
cholesterol
requir
viru
entri
virus
alfaherpesviru
subfamili
particular
hsv
entri
inhibit
cholesterol
sequest
drug
dosedepend
manner
inhibitori
effect
fulli
revers
cholesterol
replenish
bender
et
al
rahn
et
al
desplanqu
et
al
demonstr
cholesterol
import
prv
infect
stabil
infect
varicellazost
viru
vzv
sensit
agent
disrupt
lipid
raft
remov
cholesterol
dosedepend
manner
exert
effect
target
cell
viral
membran
effect
cholesterol
deplet
howev
seen
viral
bind
hambleton
et
al
inhibitor
studi
support
role
fusion
process
human
herpesviru
entri
suggest
cholesterol
present
viral
envelop
key
compon
viral
entri
huang
et
al
compar
analysi
lipid
composit
cyprinu
herpesviru
member
new
alloherpesvirida
viru
famili
herpesviral
order
common
carp
brain
ccb
membran
fraction
reveal
strong
similar
lipid
composit
ccb
lipid
raft
recent
studi
demonstr
cholesterolrich
lipid
raft
import
replic
cycl
especi
entri
egress
brogden
et
al
present
studi
role
lipid
raft
infect
mdbk
cell
evalu
separ
analysi
three
import
phase
viru
infect
bind
entri
postentri
differ
requir
cholesterol
cellular
viral
membran
product
infect
observ
interestingli
cholesterol
sequest
drug
experiment
condit
employ
prejudic
bind
mdbk
cell
contrari
cell
membran
cholesterol
requir
replic
viru
entri
phase
dosedepend
reduct
viru
yield
observ
treatment
corrobor
decreas
infect
result
cholesterol
deplet
plasma
membran
replenish
exogen
cholesterol
inhibitori
effect
revers
requir
host
cholesterol
postentri
step
also
evalu
mdbk
cell
treat
cholesterol
sequest
drug
viru
entri
analysi
reveal
viru
replic
inhibit
compar
reduct
control
cell
pretreat
infect
effect
moder
suggest
cholesterol
mainli
requir
viru
entri
rather
postentri
stage
viru
cholesterol
deplet
result
reduct
infect
sever
envelop
virus
belong
quit
differ
viral
famili
human
immunodefici
viru
hiv
guyad
et
al
zhu
et
al
human
herpesviru
huang
et
al
vzv
hambleton
et
al
prv
desplanqu
et
al
transmiss
gastroenter
viru
tgev
ren
et
al
canin
coronaviru
ccov
pratelli
colao
influenza
viru
sun
whittak
duck
hepat
b
viru
dhbv
funk
et
al
canin
distemp
viru
cdv
imhoff
et
al
dengu
viru
denv
carro
damont
hepat
c
viru
hcv
aizaki
et
al
lassa
viru
schlie
et
al
suscept
inactiv
effect
treatment
dosedepend
manner
loss
infect
revers
cholesterol
replenish
confirm
cholesterol
deplet
respons
decreas
infect
suscept
infect
treatment
may
relat
modal
envelop
develop
envelop
virus
assembl
capsid
cytoplasm
becom
envelop
bud
plasma
membran
cytoplasm
membran
virus
assembl
capsid
nucleu
fundament
problem
transport
capsid
across
nuclear
membran
rel
small
nonenvelop
virus
polyomavirus
move
nuclear
pore
larger
nonenvelop
virus
adenovirus
disrupt
nuclear
envelop
herpesviru
capsid
larg
move
nuclear
pore
consequ
develop
rather
complex
process
matur
viru
promot
primari
envelop
capsid
bud
inner
leaflet
nuclear
membran
transloc
capsid
cytoplasm
loss
primari
envelop
fusion
outer
leaflet
nuclear
membran
releas
cytoplasm
nonenvelop
capsid
acquir
secondari
envelop
bud
vesicl
transgolgi
network
matur
virion
secret
cell
mettenleit
howev
intracellular
distribut
cholesterol
uniform
major
fraction
display
plasma
membran
lang
result
part
close
associ
sphingomyelin
anoth
point
reflect
aris
result
report
present
studi
cholesterolsequest
drug
inhibit
infect
underlin
requir
host
viral
cholesterol
observ
popik
et
al
possibl
suppos
viru
andor
cellular
receptor
associ
lipid
raft
recognit
host
cell
receptor
viru
first
perhap
crucial
step
initi
diseas
process
cellular
receptor
sever
envelop
nonenvelop
virus
identifi
receptor
glycoprotein
although
virus
use
lipid
carbohydr
heparan
sulfat
new
receptor
identifi
express
clone
refer
coreceptor
entri
gener
alphaherpesviru
entri
facilit
depend
interact
viral
protein
least
two
perhap
cell
surfac
receptor
spear
et
al
instanc
alter
lipid
composit
plasma
membran
modul
hcv
entri
host
cell
consequ
deplet
cholesterol
plasma
membran
alter
sphingomyelinceramid
ratio
plasma
membran
affect
hcv
entri
reduc
cell
surfac
express
tightjunct
protein
kapadia
et
al
popescu
et
al
unfortun
viru
receptor
cphv
yet
identifi
identif
prematur
state
treatment
affect
interact
cellular
receptor
affect
express
receptor
could
suitabl
assess
theori
support
futur
